Woodline Partners’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.28M Buy
205,077
+91,106
+80% +$3.23M 0.04% 488
2025
Q1
$3.87M Sell
113,971
-6,333
-5% -$215K 0.03% 566
2024
Q4
$3.91M Buy
120,304
+10,909
+10% +$355K 0.03% 531
2024
Q3
$5.33M Buy
109,395
+9,394
+9% +$458K 0.04% 379
2024
Q2
$4.43M Sell
100,001
-6
-0% -$266 0.04% 352
2024
Q1
$5.61M Buy
100,007
+7
+0% +$393 0.05% 344
2023
Q4
$6.02M Hold
100,000
0.07% 291
2023
Q3
$6.72M Sell
100,000
-69,305
-41% -$4.66M 0.08% 272
2023
Q2
$11.7M Buy
169,305
+37,865
+29% +$2.61M 0.14% 188
2023
Q1
$6.34M Sell
131,440
-7,527
-5% -$363K 0.09% 258
2022
Q4
$6.94M Buy
138,967
+7,467
+6% +$373K 0.09% 267
2022
Q3
$5.37M Sell
131,500
-1,039,551
-89% -$42.4M 0.08% 277
2022
Q2
$64.4M Hold
1,171,051
0.99% 9
2022
Q1
$42.6M Sell
1,171,051
-307,615
-21% -$11.2M 0.69% 26
2021
Q4
$68.9M Buy
1,478,666
+72
+0% +$3.36K 0.99% 15
2021
Q3
$74.8M Buy
1,478,594
+1,205,551
+442% +$61M 1.22% 10
2021
Q2
$11.2M Buy
+273,043
New +$11.2M 0.21% 124
2021
Q1
Sell
-431,418
Closed -$12.1M 452
2020
Q4
$12.1M Buy
+431,418
New +$12.1M 0.32% 95
2020
Q3
Sell
-193,857
Closed -$8.25M 197
2020
Q2
$8.25M Buy
+193,857
New +$8.25M 0.33% 82